SMTL ID : 3e32.1 (2 other biounits)

Protein farnesyltransferase complexed with FPP and ethylenediamine scaffold inhibitor 2

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.45 Å

Oligo State

hetero-oligomer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 4 residues within 4Å: Chain B: D.297, C.299, H.362 Ligands: ED2.3 4 PLIP interactions: 4 interactions with chain B Metal complexes: B:D.297, B:D.297, B:C.299, B:H.362

1 x FPP: FARNESYL DIPHOSPHATE(Non-covalent)

FPP.2: 13 residues within 4Å: Chain A: K.164, Y.166 Chain B: W.102, R.202, H.248, G.250, Y.251, C.254, R.291, K.294, Y.300, W.303 Ligands: ED2.3 20 PLIP interactions: 17 interactions with chain B, 3 interactions with chain A Hydrophobic interactions: B:W.102, B:Y.251, B:W.303 Water bridges: B:R.291, B:K.294, B:K.294, B:K.294, B:K.294, B:L.295, B:L.295, B:L.295, B:Y.300, A:K.164, A:K.164 Salt bridges: B:H.248, B:R.291, B:R.291, B:K.294, B:K.294, A:K.164

1 x ED2: N-BENZYL-N-(2-{(4-CYANOPHENYL)[(1-METHYL-1H-IMIDAZOL-5-YL)METHYL]AMINO}ETHYL)-1-METHYL-1H-IMIDAZOLE-4-SULFONAMIDE(Non-covalent)

ED2.3: 13 residues within 4Å: Chain B: Y.93, L.96, S.99, W.102, W.106, D.297, C.299, D.359, F.360, Y.361, H.362 Ligands: ZN.1, FPP.2 7 PLIP interactions: 7 interactions with chain B Hydrophobic interactions: B:W.106, B:Y.361 Hydrogen bonds: B:F.360, B:Y.361, B:Y.361 pi-Stacking: B:W.102, B:Y.361

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hast, M.A. et al., Structural basis for binding and selectivity of antimalarial and anticancer ethylenediamine inhibitors to protein farnesyltransferase. Chem.Biol. (2009)

Release Date

2009-03-10

Peptides

Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha: A
Protein farnesyltransferase subunit beta: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha

Protein farnesyltransferase subunit beta

Related Entries With Identical Sequence